| From : | Isler, Ayhan <ayhan.isler@roche.com> |
| To : | Nino Gvenetadze <ngvenetadze@moh.gov.ge> |
| Subject : | Re: Roche SARS-CoV-2 Rapid Antigen Test |
| Cc : | Nino Kvernadze <ninokvernadze@moh.gov.ge>; Lia Tavadze <ltavadze@moh.gov.ge>; Giorgi Kobaladze <gkobaladze@moh.gov.ge>; Irakli Lomsadze <irakli.lomsadze@mirco.ge>; Maka Andronikashvili <maka.andronikashvili@gmail.com>; Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>; Ilyas Tazabekov <ilyas.tazabekov@roche.com> |
| Received On : | 28.09.2020 10:10 |
| Attachments : |
Ayhan ISLER
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Gizlilik Uyarısı : Bu mesajdaki bilgi sadece yukarıda ismi yazılı alıcının dikkatine gönderilmiştir. Eğer bu mesajın ulaştığı kişi yukarıda anılan alıcı veya o şahıs veya kuruluş adına e-mail mesajı kabul etmeye yetkili şahıs veya kuruluş değilse, işbu mesajın herhangi bir şekilde çoğaltılması, başkalarına dağıtılması veya açıklanması yasaktır. Eğer bu mesaj yanlışlık sonucu size ulaştıysa, lütfen bizi cevabi mesaj göndererek acilen haberdar ediniz ve orijinal mesajı da imha ediniz.
Confidentiality Notice : The information contained in this message is intended only for the confidential use of the above named recipient and may be subject to attorney-client privilege. If the reader of this message is not the intended recipient or person responsible for delivering to the intended recipient you are hereby notified that you have received this communication in error, and that any review, dissemination, distribution, or copying of this communication is strictly prohibited. If you have received this communication in error, please notify the sender immediately by return message. Thank you.
Dear Nino,Hope you are doing well,Although I have informed our distributor (Mirco) in Georgia, I would like to inform you as well regarding our rapid antigen SARS Cov-19 test.Roche to launch SARS-CoV-2 Rapid Antigen Test in countries accepting CE mark, allowing fast triage decisions at point of care- Antigen test reliably and quickly triages people suspected of SARS-CoV-2, with results ready in 15 minutes, allowing informed treatment decisions- Antigen test accurately screens individuals with known exposure to infected SARS-CoV-2 patients, providing fast answers regarding their infection status- Affordable and small, instrument-free testing kit enables convenient use for healthcare professionals at different point of care locations, or in resource-limited settings- Point of care testing increases access to high quality diagnostics solutions for the detection of a current SARS-CoV-2 infection, regardless of laboratory testing infrastructure or patient mobilityAbout the SARS-CoV-2 Rapid Antigen Test- Roche’s SARS-CoV-2 Rapid Antigen Test is a rapid chromatographic immunoassay intended for the qualitative detection of a specific antigen of SARS-CoV-2 present in human nasopharynx. This test is performed by healthcare professionals using a nasopharyngeal swab collected from a patient.1 The results are intended to aid in the early diagnosis of SARS-CoV-2 infection in patients showing clinical symptoms of SARS-CoV-2 and assist in the initial screening of patients. The test has a sensitivity of 96.52% and a specificity of 99.68%, based on 426 samples from two independent study centers. Results are ready in only 15 minutes.1 This test is another important addition to the testing options for SARS-CoV-2 at the point of care, following the launch of the SARS-CoV-2 Rapid Antibody Test, in July 2020, that is helping healthcare professionals identify patients that have developed antibodies against SARS-CoV-2, indicating prior infection.You can have detailed information from Mirco for purchasing this product.Have a nice week.KR,AyhanAyhan ISLER
Export Sales SpecialistRoche Diagnostics Turkey A.S.Esentepe Mahallesi, Kirgulu Sokak, No: 434394 Sisli -Istanbul /Turkey
GSM : +90 530 370 01 38e-m@il : ayhan.isler@roche.com
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Gizlilik Uyarısı : Bu mesajdaki bilgi sadece yukarıda ismi yazılı alıcının dikkatine gönderilmiştir. Eğer bu mesajın ulaştığı kişi yukarıda anılan alıcı veya o şahıs veya kuruluş adına e-mail mesajı kabul etmeye yetkili şahıs veya kuruluş değilse, işbu mesajın herhangi bir şekilde çoğaltılması, başkalarına dağıtılması veya açıklanması yasaktır. Eğer bu mesaj yanlışlık sonucu size ulaştıysa, lütfen bizi cevabi mesaj göndererek acilen haberdar ediniz ve orijinal mesajı da imha ediniz.
Confidentiality Notice : The information contained in this message is intended only for the confidential use of the above named recipient and may be subject to attorney-client privilege. If the reader of this message is not the intended recipient or person responsible for delivering to the intended recipient you are hereby notified that you have received this communication in error, and that any review, dissemination, distribution, or copying of this communication is strictly prohibited. If you have received this communication in error, please notify the sender immediately by return message. Thank you.